| 著者名 | 標題 | 誌名 |
|---|---|---|
| Kato T, Furukawa J, Hinata N, Ueda K, Hara I, Hongo F, Mizuno R, Okamoto T, Okuno H, Ito T, Kajita M, Oya M, Tomita Y, Shinohara N, Eto M, Uemura H: | Real-world outcomes of avelumab plus axitinib in patients with advanced renal cell carcinoma in Japan: long-term follow-up from the J-DART2 retrospective study. | Int J Clin Oncol 30 (1): 99-109, 2025 |
| Shiota M, Tanegashima T, Tsukahara S, Mutaguchi J, Goto S, Kobayashi S, Matsumoto T, Eto M: | Laparoscopic Retroperitoneal Lymph Node Dissection After Chemotherapy for Nonseminomatous Testicular Germ-Cell Tumor at a Single Center. | Asian J Endosc Surg 18 (1): e13416, 2025 |
| Kobayashi S, Nakadate R, Miyata S, Tsukino K, Mutaguchi J, Ueda S, Matsumoto T, Monji K, Shiota M, Inokuchi J, Eto M: | Feasibility of a new L43K ultrasound probe attachment for intraoperative laparoscopic ultrasonography in robot-assisted partial nephrectomy. | Current Urology, 1-7, 2025 |
| Blas L, Shiota M, Onozawa M, Joung JY, Koo KC, Türkeri L, Şahin B, Lim J, Ong TA, Chiu PK, Ng CF, Wu TL, Le Chuyen V, Lojanapiwat B, Letran JL, Hakim L, Chiong E, Al-Edwan GM, Taguchi S, Yamamoto Y, Sakamoto S, Kawai T, Eto M, Nakagawa T, Hinotsu S, Kume H; Asian Prostate Cancer (A-CaP) study group: | Primary management of prostate cancer by universal health coverage effective coverage index. | World J Urol 43 (1): 146, 2025 |
| Shiota M, Tanegashima T, Tatarano S, Kamoto T, Matsuyama H, Sakai H, Igawa T, Kamba T, Fujimoto N, Yokomizo A, Naito S, Eto M: | The effect of human leukocyte antigen genotype on survival in advanced prostate cancer treated with primary androgen deprivation therapy: the KYUCOG-1401-A study. | Prostate Cancer Prostatic Dis 28 (1): 193-201, 2025 |
| Tanegashima T, Shiota M, Terada N, Saito T, Yokomizo A, Kohei N, Goto T, Kawamura S, Hashimoto Y, Takahashi A, Kimura T, Tabata KI, Tomida R, Hashimoto K, Sakurai T, Shimazui T, Sakamoto S, Kamiyama M, Tanaka N, Mitsuzuka K, Kato T, Narita S, Yasumoto H, Teraoka S, Kato M, Osawa T, Nagumo Y, Matsumoto H, Enokida H, Sugiyama T, Kuroiwa K, Kitamura H, Kamoto T, Eto M; Japanese Urological Oncology Group: | Improved prognosis of de novo metastatic prostate cancer after an introduction of life-prolonging agents for castration-resistant prostate cancer. | Int J Clin Oncol 30 (3): 551-558, 2025 |
| Yokomoto-Umakoshi M, Fujita M, Umakoshi H, Ogasawara T, Iwahashi N, Nakatani K, Kaneko H, Fukumoto T, Nakao H, Haji S, Kawamura N, Shimma S, Seki M, Suzuki Y, Izumi Y, Oda Y, Eto M, Ogawa S, Bamba T, Ogawa Y: | Multiomics analysis unveils the cellular ecosystem with clinical relevance in aldosterone-producing adenomas with KCNJ5 mutations. | Proc Natl Acad Sci USA 122 (9): e2421489122, 2025 |
| 辻田次郎、種子島時祥、塚原茂大、牟田口淳、後藤駿介、小林 聡、松元 崇、塩田真己、江藤 正俊: | 九州大学泌尿器科学教室における2021年から2023年の3年間の臨床統計. | 西日本泌尿器科 87 (3): 110-114, 2025 |
| Furukawa J, Kato T, Yamasaki T, Monji K, Tanaka T, Tsuchiya N, Miyagawa T, Yaegashi H, Sano T, Karashima T, Fujita K, Hori JI, Ito T, Kajita M, Tomita Y, Shinohara N, Eto M, Oya M, Uemura H: | Real-world outcomes with avelumab + axitinib in patients with advanced renal cell carcinoma in Japan: subgroup analyses from the J-DART2 study by International Metastatic Renal Cell Carcinoma Database Consortium risk classification. | Int J Clin Oncol 30 (4): 749-760, 2025 |
| Grünwald V, McKay RR, Buchler T, Eto M, Park SH, Takagi T, Zanetta S, Keizman D, Suárez C, Négrier S, Lee JL, Santini D, Bedke J, Staehler M, Kollmannsberger C, Choueiri TK, Motzer RJ, Burgents JE, Xie R, Okpara CE, Powles T: | Clinical outcomes by baseline metastases in patients with renal cell carcinoma treated with lenvatinib plus pembrolizumab versus sunitinib: Post hoc analysis of the CLEAR trial. | Int J Cancer 156 (7): 1326-1335, 2025 |
| Ohba K, Osawa T, Kojima T, Hara T, Sugimoto M, Eto M, Minami K, Nakai Y, Ueda K, Naito S, Nonomura N, Murai S, Nishiyama H, Nakanishi H, Mukae Y, Mitsunari K, Matsuo T, Imamura R, Shinohara N: | Characteristics of patients with metastatic renal cell carcinoma who do not respond to axitinib treatment. | Int J Clin Oncol 30 (4): 781-788, 2025 |
| Shiota M, Nemoto S, Ikegami R, Tanegashima T, Blas L, Miyake H, Takahashi M, Oya M, Tsuchiya N, Masumori N, Kobayashi K, Obara W, Shinohara N, Fujimoto K, Nozawa M, Ohba K, Ohyama C, Hashine K, Akamatsu S, Motoshima T, Mita K, Gotoh M, Tatarano S, Fujisawa M, Tomita Y, Mukai S, Ito K, Eto M: | Predictive Model of Objective Response to Nivolumab Monotherapy for Advanced Renal Cell Carcinoma by Machine Learning Using Genetic and Clinical Data: The SNiP-RCC Study. | JCO Clin Cancer Inform 9: e2400167, 2025 |
| Tsukahara S, Shiota M, Matsumoto T, Takamatsu D, Nagakawa S, Noda N, Matsumoto S, Yagi M, Uchiumi T, Kunisaki Y, Kang D, Eto M: | Monitoring circulating tumor DNA by recurrent hotspot mutations in bladder cancer. | BJC Rep 3 (1): 26, 2025 |
| Matsubara N, Osawa T, Abe T, Oya M, Nishimoto K, Iwahori T, Tsuchiya H, Murota M, Yoshida M, Tatematsu Y, Nakano Y, Eto M, Nonomura N: | FGFR2/3 Gene Alterations and Clinical Outcomes in Advanced/Metastatic Urothelial Cancer in Japan: MONSTAR-SCREEN Database Study. | Cancer Sci 116 (5): 1424-1432, 2025 |
| Tohi Y, Yokomizo A, Kimura T, Wakabayashi M, Shiota M, Mori K, Kato T, Tsuzuki T, Kato M, Sasaki K, Kawahara T, Eto M, Nishiyama H, Kitamura H, Sugimoto M; Urologic Oncology Study Group of Japan Clinical Oncology Group: | Nomogram predicting the outcome of salvage radiation therapy for prostate-specific antigen failure following radical prostatectomy: an exploratory analysis of a randomized, multicenter, open-label, phase 3 trial (JCOG0401). | Int J Clin Oncol 30 (5): 993-1001, 2025 |
| Taira J, Kawatoko K, Takamatsu D, Shiota M, Ogata H, Hata J, Oishi E, Sakata S, Furuta Y, Shibata M, Ohara T, Oda Y, Eto M, Ninomiya T: | Secular Trends in the Prevalence of Total and Latent Prostate Cancer over Half a Century According to Consecutive Autopsy Cases in a Japanese community: The Hisayama Study. | Eur Urol Open Sci 78: 9-15, 2025 |
| Blas L, Shiota M, Kato T, Matsumoto R, Tohi Y, Sakamoto S, Yokomizo A, Kimura T, Furukawa J, Shoji S, Kume H, Goto T, Sekine Y, Sakai Y, Matsuoka Y, Hinata N, Kamoto T, Terada N, Akamatsu S, Sugimoto M, Eto M: | Active Surveillance in Prostate Cancer With Intermediate-Risk Features: The PRIAS-JAPAN Study. | Int J Urol 32 (7): 823-827, 2025 |
| Hu Q, Kimura Y, Ikeda S, Tanaka Y, Nakanoko T, Ota M, Yoshizumi T, Eto M, Oki E: | Circulating tumor DNA monitoring detects minimal residual disease and predicts outcomes in patients with esophageal adenocarcinoma or squamous cell carcinoma after esophagectomy. | BJC Rep 3 (1): 52, 2025 |
| Kato T, Shiota M, Nishimoto K, Matsubara N, Osawa T, Abe T, Yasumizu Y, Tanaka N, Yamamoto Y, Ishizuya Y, Abutani H, Bando H, Fujisawa T, Nakamura Y, Oya M, Shinohara N, Eto M, Yoshino T, Nonomura N: | Prognostic significance of circulating tumor DNA alterations in advanced renal cell carcinoma from SCRUM-Japan MONSTAR-SCREEN: a nationwide genomic profiling project. | Br J Cancer 133 (1): 111-120, 2025 |
| Kiyozawa D, Fukuchi G, Miyamoto T, Umekita S, Takamatsu D, Kohashi K, Eto M, Oda Y: | Comprehensive mRNA Expressional Analysis of SMARCB1-Deficient Renal Cell Carcinoma in Patients Without Hemoglobinopathies. | Genes Chromosomes Cancer 64 (8): e70069, 2025 |
| 月野圭治、小林 聡、牟田口淳、塚原茂大、種子島時祥、後藤駿介、松元 崇、塩田真己、江藤正俊: | ロボット支援腎部分切除術の手術ナビゲーションにおける自動追尾用アタッチメントの改良. | Japanese Journal of Endourology and Robotics 38 (1): 168-171, 2025 |
| Murakami Y, Yamaguchi T, Goya M, Higashijima K, Tobu S, Sato R, Tatarano S, Mukai S, Uemura KI, Tatsugami K, Tsubouchi K, Shida Y, Ishii T, Sakai H, Matsuoka H, Haga N, Eto M, Igawa T, Kamoto T, Enokida H, Shin T, Noguchi M, Fujimoto N, Saitoh S, Kamba T: | Penile Cancer: Differences Between Patients Over and Under the Age of 75 Years. | Int J Urol 32 (8): 1025-1032, 2025 |
| Tsukahara S, Shiota M, Nagakawa S, Tanegashima T, Kobayashi S, Matsumoto T, Eto M: | Nationwide Genomic Data Analysis of Japanese Prostate Cancer Patients From C-CAT Database. | Cancer Med 14 (15): e71085, 2025 |
| 溝脇尚志、細野 眞、上村博司、江藤正俊、大家基嗣、三宅秀明、池田公史、金ヶ崎彩子、櫻木俊輔、 老田侑平、絹谷清剛： | 離散事象シミュレーションによる核医学治療の待機期間の変化予測と適切な治療提供体制の検討. | 核医学 62 (1): 59-70, 2025 |
| Kashiwagi E, Ushijima M, Ueda S, Sugita Y, Mizushima Y, Matsukawa T, Kimuro R, Jojima K, Higashijima K, Nagata Y, Minato A, Tomisaki I, Eto M: | Visfatin Promotes Renal Cell Carcinoma Progression: Evidence from Clinical Samples and Cell Line Models. | J Kidney Cancer VHL 12 (3): 58-65, 2025 |
| Osawa T, Matsubara N, Kato T, Shiota M, Nishimoto K, Abe T, Shinohara N, Yasumizu Y, Tanaka N, Oya M, Abutani H, Oda T, Fujisawa T, Nakamura Y, Sivakumar S, Eto M, Yoshino T, Nonomura N: | Genomic alteration and clinical significance of circulating tumor DNA in patients with advanced urothelial cancer: SCRUM-Japan monstar screen project. | NPJ Precis Oncol 9 (1): 362, 2025 |
| Teishima J, Shiroki R, Takagi T, Eto M, Morizane S, Yamasaki T, Kohjimoto Y, Hongo F, Tsujino T, Bekku K, Hinata N, Okada A, Yoshida T, Kondo T, Kawamorita N, Yamamoto H, Isotani S, Shimbo M, Nagayama J, Yamaguchi K, Kinoshita H, Miyake H: | Extended Follow-Up of Robot-Assisted Partial Nephrectomy for Renal Hilar Tumor: A Prospective Multi-Institutional Study (ROBOHIT Trial). | Int J Urol 32 (9): 1165-1171, 2025 |
| Kuma Y, Kido-Nakahara M, Kuba-Fuyuno Y, Matsumoto T, Oda Y, Eto M, Nakahara T: | Enfortumab Vedotin-Related Skin Toxicities: Insights From Clinical and Histopathological Analysis. | J Dermatol 52 (10): 1584-1588, 2025 |
| Schwarz A, Arimura H, Cui Y, Shimabukuro S, Lin Q, Jin Y, Kobayashi S, Matsumoto T, Shiota M, Eto M, Oda Y: | Fractal dimensions for tumour-related cell types of prostate cancer on histopathology images using multiple-threshold box counting algorithm. | Biophys Physicobiol 22 (4): e220026, 2025 |
| Shibayama Y, Arimura H, Takayama Y, Kinoshita F, Takamatsu D, Nishie A, Kobayashi S, Matsumoto T, Shiota M, Eto M, Oda Y, Ishigami K: | Explainable radiomics based on association of histopathological cell density and multiparametric MR radiomic features for high-risk stratification of prostate cancer patients. | MAGMA 38 (5): 803-815, 2025 |
| Tashiro K, Mori K, Shiota M, Fukuokaya W, Takamatsu D, Matsui Y, Kato M, Saito R, Yokomizo A, Tsutsumi M, Yamamoto Y, Edamura K, Miyake M, Morizane S, Yoshino T, Matsumoto R, Narita S, Kitamura H, Eto M, Kimura T; Japanese Urological Oncology Group: | Risk Model for Lymph Node-Positive Prostate Cancer After Radical Prostatectomy. | Int J Urol 32 (10): 1386-1392, 2025 |
| Asano D, Kudo Y, Kobayashi S, Abe T, Ohuchida K, Akahoshi K, Wakabayashi G, Shimizu K, Mun M, Iwata H, Takenaka A, Habuchi T, Tanabe M, Yoshizumi T, Ban D, Ikeda N, Eto M, Kitagawa Y, Nakamura M: | Anatomy on the Border Expert Consensus Meeting: Current Status and Future Perspectives of Three-Dimensional Image Reconstruction and Immersive Technologies in Liver Surgery. | Asian J Endosc Surg 18 (1): e70182, 2025 |
| Ichinose J, Itoh S, Narita S, Asano D, Kudo Y, Abe T, Ohuchida K, Akahoshi K, Wakabayashi G, Shimizu K, Iwata H, Takeneka A, Tanabe M, Ikeda N, Eto M, Nakamura M, Kitagawa Y, Yoshizumi T, Habuchi T, Mun M: | Consensus Meeting of Anatomy on the Border, Appropriate Use and Precautions for ICG in Liver, Lung, and Renal Surgery. | Asian J Endosc Surg 18 (1): e70175, 2025 |
| Kobayashi S, Asano D, Kudo Y, Narita S, Morizane S, Abe T, Ohuchida K, Habuchi T, Takenaka A, Wakabayashi G, Yoshizumi T, Akahoshi K, Ikeda N, Tanabe M, Nakamura M, Kitagawa Y, Eto M: | Clinical Practice and Survey of Three-Dimensional Images, Virtual Reality, Augmented Reality and Mixed Reality for Robotic-Assisted Surgery in Urology-“Anatomy on the Border” Expert Consensus Meeting. | Asian J Endosc Surg 18 (1): e70189, 2025 |
| Morizane S, Kobayashi S, Narita S, Fujii K, Abe T, Ohuchida K, Eto M, Habuchi T, Eguchi T, Nakamura M, Kitagawa Y, Takenaka A: | Current Practices for Preventing Inguinal Hernia During Radical Prostatectomy: Findings From the “Anatomy on the Border” Consensus Survey by the Japan Society for Endoscopic Surgery. | Asian J Endosc Surg 18 (1): e70185, 2025 |
| Narita S, Ichinose J, Itoh S, Kobayashi S, Morizane S, Asano D, Kudo Y, Abe T, Ohuchida K, Akahoshi K, Wakabayashi G, Shimizu K, Iwata H, Takeneka A, Tanabe M, Eto M, Ikeda N, Nakamura M, Kitagawa Y, Yoshizumi T, Mun M, Habuchi T: | Details and Updates From the Consensus Meeting on Anatomical Borders for ICG Usage in Urological Laparoscopic and Robotic Kidney Surgery. | Asian J Endosc Surg 18 (1): e70184, 2025 |
| Shiota M, Matsubara N, Kato T, Eto M, Osawa T, Abe T, Shinohara N, Nishimoto K, Yasumizu Y, Tanaka N, Oya M, Fujisawa T, Horasawa S, Nakamura Y, Yoshino T, Nonomura N: | Genomic characterization of metastatic patterns in prostate cancer using circulating tumor DNA data from the SCRUM-Japan MONSTAR SCREEN project. | J Liq Biopsy 7: 100282, 2025 |
| Tanegashima T, Shiota M, Akamatsu S, Miyake H, Takahashi M, Oya M, Tsuchiya N, Masumori N, Matsuyama H, Obara W, Shinohara N, Fujimoto K, Nozawa M, Ohba K, Ohyama C, Hashine K, Kamba T, Mita K, Gotoh M, Tatarano S, Fujisawa M, Tomita Y, Mukai S, Ito K, Tokunaga S, Eto M; SNiP‐RCC investigators: | GWAS Identifies SNPs Associated With Severe Adverse Events and Efficacy in Advanced Renal Cell Carcinoma Treated With Nivolumab. | Cancer Sci 116 (12): 3300-3308, 2025 |
| Zhang S, Akahoshi T, Yoshizumi T, Eto M: | “Noninvasive predictive marker for esophageal variceal bleeding”. | BMC Gastroenterol 26 (1): 56, 2025 |
| Shiota M, Liu Y, Mundle S, Nematian-Samani M, Hwang J, Wang X, Uemura H: | The impact of androgen receptor pathway inhibitors as starting treatment in metastatic castration-sensitive prostate cancer on patient outcomes (OASIS Japan). | Sci Rep 15 (1): 13598, 2025 |
| Nagumo Y, Hattori K, Kimura T, Sekino Y, Naiki T, Kobayashi Y, Matsumoto T, Osawa T, Kita Y, Takemura M, Mathis BJ, Suzuki S, Tsuzuki T, Ishikawa H,Nishiyama H: | Combined Molecular Subclass and Immune Phenotype Correlate to Atezolizumab Plus Radiation Therapy Response in Invasive Bladder Cancer: BPT-ART Phase 2 Study. | Int J Radiat Oncol Biol Phys 122 (1): 168-180, 2025 |
| Tohi Y, Yokomizo A, Matsumoto R, Mori K, Sakamoto S, Shiota M, Sekine Y, Kanno T, Kato T, Fukuhara H, Sakai Y, Kohjimoto Y, Matsuda I, Goto T, Kawamura N, Kusuhara Y, Hashine K, Tsumura H, Naito Y, Sugimoto M; PRIAS-JAPAN: | Temporal changes in the urologist’s practice behaviour of active surveillance for prostate cancer: analysis of prospective observational study cohort. | Jpn J Clin Oncol 55 (10): 1170-1176, 2025 |